The use of continuous infusion of factor concentrates in the treatment of hemophilia
- 1 September 1989
- journal article
- Published by Wiley in American Journal of Hematology
- Vol. 32 (1), 8-13
- https://doi.org/10.1002/ajh.2830320103
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Cause of death in hemophilia a patients in the United States from 1968 to 1979American Journal of Hematology, 1988
- Comparison of continuous and intermittent factor VIII concentrate therapy in hemophilia AAmerican Journal of Hematology, 1984
- The benefits of comprehensive care of hemophilia: a five-year study of outcomes.American Journal of Public Health, 1984
- Fatal Myocardial Necrosis Associated with Prothrombin-Complex–Concentrate Therapy in Hemophilia ANew England Journal of Medicine, 1983
- Thrombogenic Materials in Prothrombin Complex ConcentratesAnnals of Internal Medicine, 1974
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Continuous Intravenous Infusion of Factor VIII in Classic HaemophiliaBritish Journal of Haematology, 1970
- The Fate of Prothrombin and Factors VIII, IX and X Transfused to Patients Deficient in these FactorsBritish Journal of Haematology, 1963
- Studies on the Nature of the Circulating Anticoagulant Directed against Antihemophilic Factor: With Notes on an Assay for Antihemophilic FactorBlood, 1962